Study Shows Peritoneal Mesothelioma Surgery Underutilized
The continued underutilization of aggressive surgery for peritoneal mesothelioma is shortening survival time dramatically for patients who could qualify for, and benefit from, the highly effective procedure.
Only a third of those diagnosed with peritoneal mesothelioma are undergoing potentially curative cytoreductive mesothelioma surgery, according to a comprehensive study of the National Cancer Database by researchers at Inova Fairfax Medical Center in Virginia.
The mesothelioma study was published earlier this year.
“Patients who have the surgery perform much better than those who do not. Yet most people do not have surgery,” Dr. Timothy Cannon, medical oncologist at Inova Medical Group and study co-author, said. “We’re hoping the study can raise awareness to this paradox.”
Source: National Cancer Database